US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

StaphWash+Plus+ Skin Protectant

Reason GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.

Phillips Co. NDC 43074-101-01 D-0951-2017
Class II · Moderate risk Terminated

StingMed Insect bites Skin Protectant. Zinc acetate

Reason GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.

Phillips Co. NDC 04307-100-11 D-0950-2017
Class II · Moderate risk Terminated

Diabecline brand Topical Ointment First Aid Antibiotic

Reason GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.

Phillips Co. NDC 04307-100-11 D-0949-2017
Class II · Moderate risk Terminated

TetraStem brand Topical Ointment First Aid Antibiotic

Reason GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.

Phillips Co. NDC 04307-301-11 D-0948-2017
Class II · Moderate risk Terminated

Tetracycline-ABC Brand Topical ointment First Aid Antibiotic

Reason GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.

Phillips Co. D-0947-2017
Class II · Moderate risk Terminated

NasalCrom

Reason CGMP Deviations: Possibility of the presence of microbial contamination in the water used to manufacture this product lot.

Bausch & Lomb, Inc. D-0899-2017
Class II · Moderate risk Terminated

Progesterone Injection in Olive Oil With Benzyl Alcohol 10%

Reason Lack of Processing Controls: The metal container closure adheres to the rubber stopper on some of the units of the batch which can impact the integrity of the container closure.

Apothecary By Design D-0924-2017
Class II · Moderate risk Terminated

Doxycycline Hyclate USP

Reason Labeling: Not Elsewhere Classified. Manufacturer and product were discovered to be on FDA Import Alert 66-66 for misbranding of active pharmaceutical ingredient.

American Pharmaceutical Ingredients LLC D-0927-2017
Class II · Moderate risk Terminated

methylcobalamin 1mg/1mL

Reason Lack of Assurance of Sterility

MedPark Pharmacy, LLC D-0888-2017
Class II · Moderate risk Terminated

Option 2

Reason Defective Container: Carton is missing the tablet blister strip and tablet.

L. Perrigo Company NDC 0113-2003-12 D-0887-2017
Class II · Moderate risk Terminated

Methocarbamol

Reason CGMP Deviations: Lack of quality assurance at the API manufacturer.

American Pharmaceutical Ingredients LLC D-0937-2017
Class II · Moderate risk Terminated

Caffeine Powder

Reason Marketed without an Approved NDA/ANDA: The product consists of pure, powdered caffeine and is an unapproved drug due to stimulant claims. The product is also misbranded as it fails to bear adequate directions for its intended use.

Global Marketing Enterprises, Inc. D-1096-2017
Class II · Moderate risk Terminated

Zenatane

Reason Failed Dissolution Specifications: out of specification results observed for low dissolution.

Dr. Reddy's Laboratories, Inc. NDC 55111-137-81 D-0886-2017
Class II · Moderate risk Terminated

Zenatane

Reason Failed Dissolution Specifications: out of specification results observed for low dissolution.

Dr. Reddy's Laboratories, Inc. NDC 55111-113-81 D-0885-2017
Class II · Moderate risk Terminated

Zenatane

Reason Failed Dissolution Specifications: out of specification results observed for low dissolution.

Dr. Reddy's Laboratories, Inc. NDC 55111-136-81 D-0884-2017
Class II · Moderate risk Terminated

Zenatane

Reason Failed Dissolution Specifications: out of specification results observed for low dissolution.

Dr. Reddy's Laboratories, Inc. NDC 55111-135-81 D-0883-2017
Class II · Moderate risk Terminated

Levophed norepinephrine bitartrate

Reason GMP Deviation; A foreign stopper was observed during packaging of a lot of product.

Hospira Inc., A Pfizer Company NDC 0409-3375-04 D-0898-2017
Class II · Moderate risk Terminated

Saphris 10 mg

Reason Labeling; Label Mixup; blister lidding foil and shell-pack labeled as 10 mg but package actually contains 5 mg tablets

Forest Laboratories, LLC NDC 0456-2410-60 D-0880-2017